For a video that ties much of this together, listen to Dr. Lee Merrit discuss cancer and COVID and the success of anti-parasitic medications.  Go here for a brief summary, but take the time to listen to Merrit.

Lyme/MSIDS patients have already been warned by Dr. McDonald that there is a connection between Lyme and cancer.  Now, with new Turbo cancers on the rise, it’s more important than ever to have effective treatments.  The establishment has essentially failed again in treating this monster and doctors/researchers that have had success are “disappeared.”  

https://justusrhope.substack.com/p/celebrity-beats-stage-4-cancer-with

Celebrity Beats Stage 4 Cancer with Repurposed Drugs

Fenbendazole Cocktail Gets the Credit

 
Article Excerpts:

When Captain Kevin Hennings, Florida Keys Fishing Guide to the Stars, contracted Stage 4 Colon Cancer, his world collapsed.

He tells his story to comedian Jim Breuer between fits of laughter about how he went from a televised celebrity to a dying patient, and how he now has become a better person for it.

He shared the dire news with his wife and family, and they supported his decision to undergo the conventional treatments of surgery, radiation, and chemotherapy. While the official 5-year survival rates are around 13%, Kevin fought the cancer like he would fight a military opponent – to beat it.

Unfortunately, sometime in September of 2021, despite three years of grueling chemotherapy, his medical team informed him that he was going to lose the battle. They told him to begin hospice and prepare for the worst, as they had no further treatment options.

His spiritual sister explained that an acquaintance from church had a friend with Stage 4 colon cancer who had opted out of chemotherapy. Instead, he took Fenbendazole, an antiparasitic agent. And she explained, he fully recovered.  (See link for article and interview)

_________________

https://www.mdpi.com/2673-4087/4/3/19

The Probable Infectious Origin of MS

by 1,2 and 1,2,*

NeuroSci 20234(3), 211-234; https://doi.org/10.3390/neurosci4030019
Submission received: 18 July 2023 / Revised: 17 August 2023 / Accepted: 25 August 2023 / Published: 7 September 2023

Abstract

Multiple sclerosis (MS) is an immune inflammatory disease that causes demyelination of the white matter of the central nervous system. It is generally accepted that the etiology of MS is multifactorial and believed to be a complex interplay between genetic susceptibility, environmental factors, and infectious agents. While the exact cause of MS is still unknown, increasing evidence suggests that disease development is the result of interactions between genetically susceptible individuals and the environment that lead to immune dysregulation and CNS inflammation. Genetic factors are not sufficient on their own to cause MS, and environmental factors such as viral infections, smoking, and vitamin D deficiency also play important roles in disease development. Several pathogens have been implicated in the etiology of MS, including Epstein–Barr virus, human herpesvirus 6, varicella-zoster virus, cytomegalovirus, Helicobacter pyloriChlamydia pneumoniae, and Borrelia burgdorferi. Although vastly different, viruses and bacteria can manipulate host gene expression, causing immune dysregulation, myelin destruction, and neuroinflammation. This review emphasizes the pathogenic triggers that should be considered in MS progression.

https://justusrhope.substack.com/p/ivermectin-cancer-study-begins?

Ivermectin Cancer Study Begins

Observing the Effects of Ivermectin on Turbo Cancers

 

Dr. Harvey Risch, one of the world’s most esteemed epidemiologists, has stated that Turbo Cancers represent a new and different type of condition. For example, Dr. Risch explains that the sudden development of colon cancer in a young person with no known family history means that something completely novel is now happening to cause this.

Dr. Harvey Risch is a Professor Emeritus of Epidemiology at Yale University.

“Cancer as a disease takes a long time to manifest itself from when it starts, from the first cells that go haywire until they grow to be large enough to be diagnosed or to be symptomatic, can take anywhere from two or three years for the blood cancers, like leukemias and lymphomas, to five years for lung cancer, to 20 years for bladder cancer, or 30, 35 years for colon cancer, and so on.

We know that colon cancers usually take decades to develop and begin with an adenomatous polyp. This polyp slowly undergoes malignant transformation under carcinogenic conditions – which might involve insulin resistance, diabetes, damage to mitochondria, an altered gut microbiome, lack of exercise, and an inflammatory diet. The cancer expands to gradually invade the mucosal wall, and then the surrounding tissues and lymph nodes. By the time this all plays out, the person is usually in their 50s or 60s.

In the rare cases of genetic colon cancer, like Familial Adenomatous Polyposis (FAP) or Hereditary Non-polyposis Colorectal Cancer (HNPCC), it can occur in young people. However, we are now seeing full-blown non-genetic colon cancers develop suddenly in 20, 30 and 40-year-olds in large numbers which is unprecedented.  (See link for article and video)

___________

**Comment**

Dr. Marik has taken the lead in using repurposed drugs which is why he has been heavily censored – especially about ivermectin, a cheap, safe, and effective COVID treatment, which just happens to also be working for cancer.  Go here for more, particularly about the responsive cancer types; however, Ivermectin has shown some degree of anti-cancer effect in every cancer type it has been tested on.

  • Two French researchers found that ivermectin could reverse multidrug resistance in tumors all the way back in 1995.
  • The drug targets tumor stem cells—a driver of cancer tumors and relapses—and promotes cancer death.
  • It enhances the effects of chemo and radiation therapy. It has a broad impact on the immune system, increasing immune offense against cancers.
  • It inhibits cancer cell cycles, helping prevent the formation of new cancer cells.
  • It promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells.
Dr. Peter P. Lee’s team has begun a clinical trial of ivermectin combined with the immunotherapy drug Pembrolizumab for women with metastatic breast cancer. They have also found ivermectin to be effective against other types of cancer cells. Therefore, additional patients may be included in future trials.  The interaction of the two therapies is a highly complex process dependent on timing, dosage, and drug combinations.

Marik and Dr. Kathleen Ruddy are undertaking an observational study which involves repurposed drugs and metabolic treatments for patients with advanced cancers. Ruddy has observed amazing results using ivermectin against a variety of malignancies. The new study will look at dose, timeline of administration and response to treatment.

Patients will determine the specific repurposed drugs and interventions they want and could include the following with or without traditional cancer treatments:

  • Mebendazole
  • Metformin
  • Vitamin D
  • Fish Oil
  • Curcumin
  • Green Tea
  • Melatonin
  • sunlight
  • overnight fasting
  • a ketogenic diet
  • daily resistance 
  • aerobic exercise

Expect Marik and Ruddy to be vilified as quacks. It’s what Big Pharma and its subsidiaries do to those who dare to color outside the lines. Just remember what they did to ivermectin, HCQ and those who dared to prescribe them:

Also see: